Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Metastatic × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 463 Carcinoma, Non-Small-Cell Lung 390 Ovarian Neoplasms 271 Lung Neoplasms 161 Neoplasms 126 Fallopian Tube Neoplasms 121 Esophageal Neoplasms 108 Stomach Neoplasms 103 Neoplasm Metastasis 98 Carcinoma, Ovarian Epithelial 97 Triple Negative Breast Neoplasms 94 Endometrial Neoplasms 79 Squamous Cell Carcinoma of Head and Neck 74 Head and Neck Neoplasms 66 Esophageal Squamous Cell Carcinoma 64 Uterine Cervical Neoplasms 60 Recurrence 43 Parkinson Disease 4, Autosomal Dominant Lewy Body 38 Urinary Bladder Neoplasms 37 Adenocarcinoma of Lung 36 Adenocarcinoma Of Esophagus 33 Melanoma 32 Carcinoma 32 Small Cell Lung Carcinoma 28 Prostatic Neoplasms 27 Carcinoma, Squamous Cell 27 Pancreatic Neoplasms 26 Breast Neoplasms, Male 26 Unspecified Adult Solid Tumor, Protocol Specific 25 Colorectal Neoplasms 24

Interventions

Fulvestrant 5 Letrozole 4 exemestane 3 Anastrozole 3 ribociclib 2 dalpiciclib 2 apatinib 2 Gemcitabine 2 Capecitabine 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 pyrotinib 1 patritumab deruxtecan 1 palbociclib 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Trastuzumab 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Ga(III)-DOTATOC 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04603183 2025-12-12

ABIGAIL

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡